Workman, C., Blalock, D
Midi really shines if your insurance plan includes coverage for medications like Wegovy or Zepbound , as well as HRT (hormone replacement therapy)
Wegovy coverage exists but requires BMI 30+ or BMI 27+ with comorbidities plus documented diet and exercise failure Prior authorization approval rates for diabetes indications average 73% on first submission across Kaiser regions, with denials most often citing incomplete A1C documentation or missing step therapy trials Compounded semaglutide is not covered by Kaiser or any major insurer, but costs $297 to $347 per month through cash-pay telehealth platforms, often less than brand-name copays after deductible Direct answer (40-60 words) Kaiser Permanente covers Ozempic for FDA-approved type 2 diabetes treatment on all regional formularies, but requires prior authorization demonstrating inadequate glycemic control on metformin or other first-line agents
doi: 10.3389/fphar.2014.00192 Received 13 June 2014 Accepted 26 July 2014 Published 20 August 2014 Volume 5 - 2014 Edited by Alfonso Pompella, Universit di Pisa, Italy Reviewed by Rahman M
G.KalyaniR
Expert discovery is scheduled to be completed by March 27, 2026, with motions for summary judgment due April 16, 2026, followed by preparations for the first bellwether trials